Sputnik Vaccine Efficacy Data Published in Lancet Are ‘Statistically Impossible’ 13/07/2022 Maayan Hoffman Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading -> WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> African Innovation Gets Major Boost with New Pharma Technology Foundation 07/07/2022 Ochieng’ Ogodo The African Development Bank is establishing a foundation with the aim of spending at least $3 billion over the next decade to boost Africa’s access to technologies needed to make medicines, vaccines, and other pharmaceutical products. The bank’s board approved the establishment of the African Pharmaceutical Technology Foundation with an eye to towards creating what […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> World Sees ‘Unprecedented’ Hunger as Farm Subsidies Boost Unhealthy Foods 06/07/2022 Elaine Ruth Fletcher Between 702 million and 828 million people suffered from hunger in 2021, more than at any time since 2005, five UN agencies reported on Wednesday. The proportion of people affected by hunger had remained relatively unchanged since 2015, affecting 8% of the global population in 2019. Once the COVID-19 pandemic hit in early 2020, those […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Concerned About Monkeypox Spreading Among Children 29/06/2022 Kerry Cullinan Monkeypox appears to be establishing itself as a prominent danger to high-risk populations such as children, immune-compromised people and pregnant women, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned. Already, WHO said authorities confirmed cases involving two children in the UK and a child each in Spain, France and the Netherlands. Tedros, however, […] Continue reading -> Posts navigation Older postsNewer posts
WHO Issues Urgent Call to Develop New Vaccines to Tackle Drug-Resistant Bacteria 12/07/2022 Dann Okoth NAIROBI — With antimicrobial resistance (AMR) on the rise globally, the World Health Organization (WHO) Tuesday issued an urgent call to step up investment and research into vaccine candidates that can tackle the problem of drug-resistant bacteria in a new report that looks at key research gaps and opportunities. Antimicrobial resistance, which refers to bacteria, […] Continue reading -> UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> African Innovation Gets Major Boost with New Pharma Technology Foundation 07/07/2022 Ochieng’ Ogodo The African Development Bank is establishing a foundation with the aim of spending at least $3 billion over the next decade to boost Africa’s access to technologies needed to make medicines, vaccines, and other pharmaceutical products. The bank’s board approved the establishment of the African Pharmaceutical Technology Foundation with an eye to towards creating what […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> World Sees ‘Unprecedented’ Hunger as Farm Subsidies Boost Unhealthy Foods 06/07/2022 Elaine Ruth Fletcher Between 702 million and 828 million people suffered from hunger in 2021, more than at any time since 2005, five UN agencies reported on Wednesday. The proportion of people affected by hunger had remained relatively unchanged since 2015, affecting 8% of the global population in 2019. Once the COVID-19 pandemic hit in early 2020, those […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Concerned About Monkeypox Spreading Among Children 29/06/2022 Kerry Cullinan Monkeypox appears to be establishing itself as a prominent danger to high-risk populations such as children, immune-compromised people and pregnant women, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned. Already, WHO said authorities confirmed cases involving two children in the UK and a child each in Spain, France and the Netherlands. Tedros, however, […] Continue reading -> Posts navigation Older postsNewer posts
UN Human Rights Council’s Resolution on Access to Medicines and Vaccines Welcomed by Civil Society 11/07/2022 Elaine Ruth Fletcher Citizens and NGOs welcomed the United Nations Human Rights Council’s adoption of a much-debated draft resolution that calls on nations to ensure everyone has access to medicines and vaccines. The resolution was adopted by consensus Friday shortly before the close of the HRC’s 50th session, sending what proponents called a “clear message” that access to […] Continue reading -> African Innovation Gets Major Boost with New Pharma Technology Foundation 07/07/2022 Ochieng’ Ogodo The African Development Bank is establishing a foundation with the aim of spending at least $3 billion over the next decade to boost Africa’s access to technologies needed to make medicines, vaccines, and other pharmaceutical products. The bank’s board approved the establishment of the African Pharmaceutical Technology Foundation with an eye to towards creating what […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> World Sees ‘Unprecedented’ Hunger as Farm Subsidies Boost Unhealthy Foods 06/07/2022 Elaine Ruth Fletcher Between 702 million and 828 million people suffered from hunger in 2021, more than at any time since 2005, five UN agencies reported on Wednesday. The proportion of people affected by hunger had remained relatively unchanged since 2015, affecting 8% of the global population in 2019. Once the COVID-19 pandemic hit in early 2020, those […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Concerned About Monkeypox Spreading Among Children 29/06/2022 Kerry Cullinan Monkeypox appears to be establishing itself as a prominent danger to high-risk populations such as children, immune-compromised people and pregnant women, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned. Already, WHO said authorities confirmed cases involving two children in the UK and a child each in Spain, France and the Netherlands. Tedros, however, […] Continue reading -> Posts navigation Older postsNewer posts
African Innovation Gets Major Boost with New Pharma Technology Foundation 07/07/2022 Ochieng’ Ogodo The African Development Bank is establishing a foundation with the aim of spending at least $3 billion over the next decade to boost Africa’s access to technologies needed to make medicines, vaccines, and other pharmaceutical products. The bank’s board approved the establishment of the African Pharmaceutical Technology Foundation with an eye to towards creating what […] Continue reading -> Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> World Sees ‘Unprecedented’ Hunger as Farm Subsidies Boost Unhealthy Foods 06/07/2022 Elaine Ruth Fletcher Between 702 million and 828 million people suffered from hunger in 2021, more than at any time since 2005, five UN agencies reported on Wednesday. The proportion of people affected by hunger had remained relatively unchanged since 2015, affecting 8% of the global population in 2019. Once the COVID-19 pandemic hit in early 2020, those […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Concerned About Monkeypox Spreading Among Children 29/06/2022 Kerry Cullinan Monkeypox appears to be establishing itself as a prominent danger to high-risk populations such as children, immune-compromised people and pregnant women, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned. Already, WHO said authorities confirmed cases involving two children in the UK and a child each in Spain, France and the Netherlands. Tedros, however, […] Continue reading -> Posts navigation Older postsNewer posts
Long-Neglected Tuberculosis Could Be Stopped by 2030 – at a Cost of $250 Billion 07/07/2022 Kerry Cullinan After year-long consultations, the Stop TB Partnership launched its global plan to end tuberculosis by 2030, which would involve the diagnosis and treatment of 50 million people at a cost of $250 billion. TB, the second biggest infectious disease killer in the world after COVID-19, has been neglected by donors in the past – yet […] Continue reading -> World Sees ‘Unprecedented’ Hunger as Farm Subsidies Boost Unhealthy Foods 06/07/2022 Elaine Ruth Fletcher Between 702 million and 828 million people suffered from hunger in 2021, more than at any time since 2005, five UN agencies reported on Wednesday. The proportion of people affected by hunger had remained relatively unchanged since 2015, affecting 8% of the global population in 2019. Once the COVID-19 pandemic hit in early 2020, those […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Concerned About Monkeypox Spreading Among Children 29/06/2022 Kerry Cullinan Monkeypox appears to be establishing itself as a prominent danger to high-risk populations such as children, immune-compromised people and pregnant women, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned. Already, WHO said authorities confirmed cases involving two children in the UK and a child each in Spain, France and the Netherlands. Tedros, however, […] Continue reading -> Posts navigation Older postsNewer posts
World Sees ‘Unprecedented’ Hunger as Farm Subsidies Boost Unhealthy Foods 06/07/2022 Elaine Ruth Fletcher Between 702 million and 828 million people suffered from hunger in 2021, more than at any time since 2005, five UN agencies reported on Wednesday. The proportion of people affected by hunger had remained relatively unchanged since 2015, affecting 8% of the global population in 2019. Once the COVID-19 pandemic hit in early 2020, those […] Continue reading -> Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Concerned About Monkeypox Spreading Among Children 29/06/2022 Kerry Cullinan Monkeypox appears to be establishing itself as a prominent danger to high-risk populations such as children, immune-compromised people and pregnant women, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned. Already, WHO said authorities confirmed cases involving two children in the UK and a child each in Spain, France and the Netherlands. Tedros, however, […] Continue reading -> Posts navigation Older postsNewer posts
Sanofi Launches Nonprofit Pharmaceuticals Line with Insulin and Cancer Treatments for Low-Income Countries 05/07/2022 John Heilprin French drugmaker Sanofi is the latest pharmaceuticals manufacturer to offer a package of essential medicines at cost to health systems in the world’s most impoverished countries – including much-needed cancer and diabetes treatments. Sanofi on Monday announced the launch of the new nonprofit Impact® brand for dozens of medicines, that is supposed to ease support […] Continue reading -> Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Concerned About Monkeypox Spreading Among Children 29/06/2022 Kerry Cullinan Monkeypox appears to be establishing itself as a prominent danger to high-risk populations such as children, immune-compromised people and pregnant women, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned. Already, WHO said authorities confirmed cases involving two children in the UK and a child each in Spain, France and the Netherlands. Tedros, however, […] Continue reading -> Posts navigation Older postsNewer posts
Buyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals 04/07/2022 Iain Barton & René Berger The wider use of pooled procurement in national health systems can help low- and middle-income countries get a better deal on pharmaceuticals – here’s how and why. Low- and middle-income countries are making strides in bolstering their domestic pharmaceutical sectors—evidenced by the recent deal between South Africa’s Afrigen Biologics and Belgium’s Univercells, to develop the […] Continue reading -> True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Concerned About Monkeypox Spreading Among Children 29/06/2022 Kerry Cullinan Monkeypox appears to be establishing itself as a prominent danger to high-risk populations such as children, immune-compromised people and pregnant women, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned. Already, WHO said authorities confirmed cases involving two children in the UK and a child each in Spain, France and the Netherlands. Tedros, however, […] Continue reading -> Posts navigation Older postsNewer posts
True Dimensions of Monkeypox Outbreak in Africa Obscured by Testing Gap 30/06/2022 Paul Adepoju WHO and Africa CDC are trying to close a huge testing gap for monkeypox that has left some health workers reliant on symptomatic diagnosis. The World Health Organization (WHO) and African Centres for Disease Control and Prevention (Africa CDC) acknowledge they will not be able to gain a clear understanding of the monkeypox outbreak in […] Continue reading -> WHO Concerned About Monkeypox Spreading Among Children 29/06/2022 Kerry Cullinan Monkeypox appears to be establishing itself as a prominent danger to high-risk populations such as children, immune-compromised people and pregnant women, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned. Already, WHO said authorities confirmed cases involving two children in the UK and a child each in Spain, France and the Netherlands. Tedros, however, […] Continue reading -> Posts navigation Older postsNewer posts
WHO Concerned About Monkeypox Spreading Among Children 29/06/2022 Kerry Cullinan Monkeypox appears to be establishing itself as a prominent danger to high-risk populations such as children, immune-compromised people and pregnant women, World Health Organization (WHO) Director-General Dr Tedros Adhanom Ghebreyesus warned. Already, WHO said authorities confirmed cases involving two children in the UK and a child each in Spain, France and the Netherlands. Tedros, however, […] Continue reading -> Posts navigation Older postsNewer posts